5th Annual TRDRP Smoking Cessation Day Symposium-Virtual 3/24/23

UPON COMPLETION PARTICIPANTS WILL BE ABLE TO:

• Recognize 3 types of medications used to treat tobacco use disorder
• Identify the role and mission of FDA’s Center for Tobacco Products and 2 ways it is different from other FDA Centers
• Explain at least 2 proposed product standards that FDA announced in 2022 and how they could help tobacco users quit
• Recall 4 terms that reflect the spirit of motivational interviewing
• Identify at least 3 multilevel determinants of smoking behaviors among African Americans
• Recall at least 2 interventions for smoking cessation in smokers who drink heavily
• Explain up to 3 alternative ways to assist a person with smoking cessation efforts

AGENDA

7:45 - 8:00 am - Zoom Opens & Welcome

8:00 - 8:30 am - Smoking Cessation Project Los Angeles County, Summary CME and CE Processes Theodore C. Friedman, MD, PhD - CDU, Brian Hurley, MD, MBA, DFASAM, FAPA - LAC DPH/SAPC, Norma Mtume, MHS, MA MFT - Friends Research Institute

8:30 – 9:15 am - Let's Hear from the Federal Government about Tobacco and Tobacco Use Disorder Atul Nakhasi, MD, MPP, U.S. Office of the Surgeon General, Director of Science & Policy, Priscilla Callahan-Lyon, MD, Senior Science Advisor, Food and Drug Administration, Center for Tobacco Products

9:15 – 10:00 am - Transdisciplinary Research to Address Racial Disparities in Lung Cancer Risk and Outcomes Chanita Hughes-Halbert, PhD, Vice Chair for Research Professor, Dept. of Population & Public Health, Dr. Arthur & Ulene Chair in Women's Cancer, Keck School of Medicine, Assoc. Dir. For Cancer Equity, Norris Comp. Cancer Center-USC

10:00 - 10:10 am - Break

10:10 - 11:00 am - African Americans Who Smoke-Attitudes Toward A Flavor Ban Karen Beard, EdD, Community PI, Certified Tobacco Treatment Specialist, Amplify, African American Statewide Coordinating Center

11:00 - 11:40 am - Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial Lara Ray, PhD, ABPP, UCLA

11:40 - 12:15 pm - Panel - Overcoming Challenges in Implementing Smoking Cessation Services: Perspectives from the Field

• Hrishikesh Belani, MD, MPH, AAHIVS, Associate Medical Director, LAC Hubert H. Humphrey Comprehensive Health Center - Moderator
• Manual Campa, MD, Primary Care Director - LAC-USC
• Bruce Boardman, CEO Soc Model Recovery
• Brian Harrell, Patient
• Rebecca Tafoya, CADC II/ ICADC, Addiction Counselor, LAC West Central Family Mental Health Center
• Lara Ray, PhD, ABPP, UCLA

12:15 - 12:25 am - Break

12:25 - 1:25 pm - Conversations about Changing Smoking Brian Hurley, MD, MBA, DFASM, FAPA – Mental Health Director - LAC DPH/SAPC

1:25 - 2:10 pm - Helping Others to Quit Tasha Dixon, LMFT - KickAsh Facilitator, Friends Research Institute

2:10 -2:30 pm Wrap-up, Closing, CME/CE Recap

Sponsored by Tobacco-Related Disease Research Program, L.A. County Health Agency, UCLA Integrated Substance Abuse Program, Charles Drew University of Medicine and Science, and Friends Research Institute

Credits Available:

Continuing Medical Education (CME) Accreditation and Continuing Education Credits (CEs)/ Contact Hours (CEHs):

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the California Medical Association (CMA) through the joint providership of UCLA Integrated Substance Abuse Programs (ISAP) and Friends Research Institute. The UCLA Integrated Substance Abuse Programs (ISAP) is accredited by the CMA to provide continuing medical education for physicians.

UCLA Integrated Substance Abuse Programs (ISAP) designates this live virtual training course for a maximum of five and one-half (5.5) AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The California Board of Registered Nursing recognizes that Continuing Medical Education (CME) is acceptable for meeting RN continuing education requirements as long as the course is certified for AMA PRA Category 1 CreditsTM (rn.ca.gov). Nurses will receive a Certificate of Participation following this activity that may be used for license renewal.

The training course meets the qualifications for the provision of five and one-half (5.5) continuing education credits/contact hours (CEs/CEHs). UCLA Integrated Substance Abuse Programs (ISAP) is approved by the American Psychological Association to sponsor continuing education for psychologists. UCLA ISAP maintains responsibility for this program and its content.

UCLA ISAP is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for LMFTs, LCSWs, LPCCs, and/or LEPs (Provider #64812). UCLA ISAP maintains responsibility for this program/course and its content. Course meets the qualifications for five and one-half (5.5) hours of continuing education credit for LMFTs, LCSWs, LPCCs, and LEPs as required by the California Board of Behavioral Sciences. UCLA ISAP is also an approved provider of continuing education for RADTs I/II, CADCs-CASs, CADCs I/II, CADCs-CSs, and LAADCs (CCAPP, #2N-00-445-1123), CATCs (ACCBC/CAADE, #CP40 872 C 0825), and CAODCs (CADTP, #151).

Continuing medical education will be awarded within 6-8 weeks following completion of the training.